Macrophage migration inhibitory factor (MIF), a novel factor regulates hyperphagia and obesity associated with atypical antipsychotics
Macrophage migration inhibitory factor (MIF), a novel factor regulates hyperphagia and obesity associated with atypical antipsychotics
批准号:
370493
负责人:
Qi Dake
金额:
$47.37万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01
中文摘要
严重的精神障碍,如精神分裂症或双相情感障碍,影响超过2%的加拿大人口,特别是青年。非典型抗精神病药(AAP)是治疗这些疾病的一线药物,但它们通常与
英文摘要
Severe mental disorders such as schizophrenia or bipolar disorder affect more than 2% of the Canadian population, especially youth. Atypical antipsychotics (AAPs) are the first-line medications for treating these diseases, while they are often associated
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金